Novel approaches to quantify CNS involvement in children with Pompe disease.

Neurology
Aditi KorlimarlaPriya Sunil Kishnani

Abstract

To characterize the extent of CNS involvement in children with Pompe disease using brain MRI and developmental assessments. The study included 14 children (ages 6-18 years) with infantile Pompe disease (IPD) (n = 12) or late-onset Pompe disease (LOPD) (n = 2) receiving enzyme replacement therapy. White matter (WM) hyperintense foci seen in the brain MRIs were systematically quantified using the Fazekas scale (FS) grading system with a novel approach: the individual FS scores from 10 anatomical areas were summed to yield a total FS score (range absent [0] to severe [30]) for each child. The FS scores were compared to developmental assessments of cognition and language obtained during the same time period. Mild to severe WM hyperintense foci were seen in 10/12 children with IPD (median age 10.6 years) with total FS scores ranging from 2 to 23. Periventricular, subcortical, and deep WM were involved. WM hyperintense foci were seen throughout the path of the corticospinal tracts in the brain in children with IPD. Two children with IPD had no WM hyperintense foci. Children with IPD had relative weaknesses in processing speed, fluid reasoning, visual perception, and receptive vocabulary. The 2 children with LOPD had no WM hyperintens...Continue Reading

References

Sep 1, 1990·Journal of the Neurological Sciences·H A KretzschmarP Mehraein
Aug 1, 1987·AJR. American Journal of Roentgenology·F FazekasR A Zimmerman
Nov 1, 1987·Radiology·A J KumarH S Mayberg
May 15, 2002·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Jung-Eun CheonKyung Mo Yeon
May 17, 2006·Genetics in Medicine : Official Journal of the American College of Medical Genetics·UNKNOWN ACMG Work Group on Management of Pompe DiseaseMichael S Watson
Jul 22, 2006·Pediatric Research·Yin-Hsiu ChienWuh-Liang Hwu
Nov 1, 2006·Laboratory Investigation; a Journal of Technical Methods and Pathology·Beth L ThurbergMichael O'Callaghan
Feb 25, 2009·Neurology·Raphael Schiffmann, Marjo S van der Knaap
Sep 19, 2009·Dysphagia·Harrison N JonesPriya S Kishnani
May 18, 2010·Pediatric Neurology·T Andrew BurrowRobert J Hopkin
Jul 3, 2010·Journal of Inherited Metabolic Disease·Carine I van CapelleAns T van der Ploeg
Oct 1, 2010·Journal of Inherited Metabolic Disease·Marianne RohrbachMatthias R Baumgartner
Jan 6, 2011·Frontiers in Neurology·Angshuman Mukherjee, Ambar Chakravarty
Jan 13, 2012·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Yoav H MessingerPriya S Kishnani
Apr 28, 2012·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Sean N PraterPriya S Kishnani
Apr 4, 2015·The American Journal of Case Reports·Lisa D Hobson-WebbPriya S Kishnani
Oct 20, 2015·Neurobiology of Disease·A James Barkovich, Sean Deon
May 13, 2017·Molecular Genetics and Metabolism·Gail A SpiridigliozziPriya S Kishnani
Oct 21, 2017·Molecular Genetics and Metabolism·Paul T McIntoshPriya S Kishnani
Mar 25, 2018·Developmental Medicine and Child Neurology·Berendine J EbbinkJohanna M P van den Hout
Oct 13, 2018·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·O MusumeciA Toscano
Jan 1, 2019·Neuromuscular Disorders : NMD·José Guevara-CamposOmar Cauli
Aug 9, 2019·Annals of Translational Medicine·Aditi KorlimarlaBaodong Sun

❮ Previous
Next ❯

Citations

Dec 21, 2021·Journal of Inherited Metabolic Disease·Jan J A van den DorpelNadine A M E van der Beek

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.